Woodline Partners LP Magenta Therapeutics, Inc. Transaction History

Woodline Partners LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$1.26 - $2.09 $468,423 - $776,988	371,765 Added 39.84%	1,304,946 $1.84 Million
Q2 2022 Aug 15, 2022	BUY	$0.97 - $3.08 $132,618 - $421,097	136,720 Added 17.17%	933,181 $1.12 Million
Q1 2022 May 16, 2022	BUY	$2.55 - $5.23 $1.36 Million - $2.78 Million	531,984 Added 201.15%	796,461 $2.31 Million
Q4 2021 Feb 14, 2022	SELL	$4.43 - $8.33 $1.11 Million - $2.09 Million	-251,193 Reduced 48.71%	264,477 $1.17 Million
Q3 2021 Nov 15, 2021	BUY	$6.07 - $9.89 $3.13 Million - $5.1 Million	515,670 New	515,670 $3.75 Million

442K

Ticker MGTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,890,500
Description
Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that ca...

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

Stay updated on Woodline Partners LP with notifications on news.